Ryan Townley

Ryan Townley, MD is an Associate Professor of Neurology at the University of Kansas Medical Center's School of Medicine. He serves as Fellowship Program Director for the Neurology department and is the Medical Director of the Memory Clinic at The University of Kansas Health System. Dr. Townley actively advances Alzheimer's research as co-Principal Investigator of the Alzheimer's Clinical Trials Consortium and leads multiple clinical studies at the University of Kansas Alzheimer's Disease Research Center.

Education:

• BS in Neurobiology, University of Kansas, Lawrence, KS
• MD, University of Kansas School of Medicine, Kansas City, KS
• Neurology Residency, Mayo School of Graduate Medical Education, Rochester, MN
• Cognitive and Behavioral Neurology Fellowship, Mayo School of Graduate Medical Education, Rochester, MN

Dr. Townley's research focuses on Alzheimer's disease variants including posterior cortical atrophy and dysexecutive Alzheimer's, dementia with Lewy bodies, normal pressure hydrocephalus, and frontotemporal lobar degeneration. His work combines clinical practice with cutting-edge research to improve diagnosis and treatment of neurodegenerative conditions. He is particularly interested in the intersection of behavioral neurology and neuropsychiatry, leveraging his dual certification in Psychiatry and Neurology to provide comprehensive patient care.

Dr. Townley's published research demonstrates a strong focus on neuroimaging techniques for diagnosing and characterizing various dementia subtypes. His work spans from basic neuropathological studies of Alzheimer's disease to clinical trials evaluating new therapeutic approaches. A significant portion of his research examines the heterogeneity of dementia presentations and seeks to refine diagnostic criteria for various neurodegenerative conditions.

Scientific Awards:

• Dewey K. Ziegler Award for Excellence in Neurology
• American Academy of Neurology's Outstanding Neurology Medical Student Award

As Fellowship Program Director, Dr. Townley mentors the next generation of cognitive and behavioral neurologists. He has secured multiple research grants from the National Institute on Aging to investigate Alzheimer's disease and related dementias. His current projects include the AHEAD 3-45 Study, a study evaluating CT1812 for Dementia With Lewy Bodies, and the Alzheimer's Plasma Extension Study, all serving as Site Principal Investigator.

Dr. Townley is actively involved with the University of Kansas Alzheimer's Disease Research Center, contributing to both clinical care and research initiatives. He serves on the Clinical Education Task Force of the Lewy Body Disease Association and is a member of the International Society to Advance Alzheimer's Research and Treatment, demonstrating his commitment to advancing knowledge and care for patients with neurodegenerative conditions.